Supplemental material
Expert Review of Vaccines
Volume 21, 2022 - Issue 3
Original Research
Progression from human papillomavirus (HPV) infection to cervical lesion or clearance in women (18–25 years): Natural history study in the control arm subjects of AS04-HPV-16/18 vaccine efficacy study in China between 2008 and 2016
Sarah Welbya GSK Vaccines Research and Development, GSK, Wavre, BelgiumCorrespondence[email protected]
https://orcid.org/0000-0003-3217-9490View further author information
https://orcid.org/0000-0003-3217-9490View further author information, Dominique Rosillona GSK Vaccines Research and Development, GSK, Wavre, Belgiumhttps://orcid.org/0000-0001-7230-1978View further author information
https://orcid.org/0000-0001-7230-1978View further author information, Yang Fengb Vaccines, Ningyang Group Co. Ltd on Behalf of GSK, Xiamen, Chinahttps://orcid.org/0000-0003-4470-6411View further author information
https://orcid.org/0000-0003-4470-6411View further author information & Dorota Borysa GSK Vaccines Research and Development, GSK, Wavre, Belgiumhttps://orcid.org/0000-0001-9704-8462View further author information
https://orcid.org/0000-0001-9704-8462View further author information